West Pharmaceutical Services ROE 2006-2018 | WST

Current and historical return on equity (ROE) values for West Pharmaceutical Services (WST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. West Pharmaceutical Services ROE for the three months ending September 30, 2018 was 15.78%.
West Pharmaceutical Services ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.16B $1.35B 11.88%
2018-06-30 $0.15B $1.28B 11.65%
2018-03-31 $0.13B $1.31B 10.42%
2017-12-31 $0.15B $1.28B 12.06%
2017-09-30 $0.19B $1.32B 15.68%
2017-06-30 $0.18B $1.24B 15.16%
2017-03-31 $0.18B $1.17B 16.13%
2016-12-31 $0.14B $1.12B 12.96%
2016-09-30 $0.14B $1.14B 12.69%
2016-06-30 $0.10B $1.11B 9.71%
2016-03-31 $0.09B $1.07B 8.33%
2015-12-31 $0.10B $1.02B 9.72%
2015-09-30 $0.09B $1.00B 9.69%
2015-06-30 $0.12B $0.99B 12.76%
2015-03-31 $0.13B $0.94B 13.85%
2014-12-31 $0.13B $0.96B 13.25%
2014-09-30 $0.12B $0.97B 12.68%
2014-06-30 $0.12B $0.97B 12.71%
2014-03-31 $0.11B $0.94B 12.48%
2013-12-31 $0.11B $0.91B 13.81%
2013-09-30 $0.11B $0.84B 14.21%
2013-06-30 $0.10B $0.78B 13.17%
2013-03-31 $0.08B $0.75B 11.70%
2012-12-31 $0.08B $0.73B 11.49%
2012-09-30 $0.08B $0.72B 11.50%
2012-06-30 $0.08B $0.68B 11.91%
2012-03-31 $0.09B $0.70B 12.42%
2011-12-31 $0.08B $0.66B 11.24%
2011-09-30 $0.06B $0.69B 9.42%
2011-06-30 $0.06B $0.70B 9.78%
2011-03-31 $0.07B $0.66B 10.59%
2010-12-31 $0.07B $0.63B 10.96%
2010-09-30 $0.08B $0.63B 13.55%
2010-06-30 $0.08B $0.57B 13.76%
2010-03-31 $0.08B $0.58B 13.64%
2009-12-31 $0.07B $0.58B 13.29%
2009-09-30 $0.07B $0.57B 13.49%
2009-06-30 $0.07B $0.53B 12.93%
2009-03-31 $0.08B $0.49B 14.59%
2008-12-31 $0.09B $0.49B 16.56%
2008-09-30 $0.07B $0.53B 14.27%
2008-06-30 $0.07B $0.55B 14.43%
2008-03-31 $0.07B $0.51B 14.21%
2007-12-31 $0.07B $0.49B 14.78%
2007-09-30 $0.08B $0.48B 17.29%
2007-06-30 $0.08B $0.49B 18.27%
2007-03-31 $0.08B $0.46B 18.23%
2006-12-31 $0.07B $0.42B 17.07%
2006-09-30 $0.07B $0.40B 17.39%
2006-06-30 $0.06B $0.39B 16.95%
2006-03-31 $0.05B $0.36B 15.50%
2005-12-31 $0.05B $0.34B 14.60%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $7.920B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.744B 21.38
McKesson (MCK) United States $25.428B 9.71
AmerisourceBergen (ABC) United States $19.755B 14.09
Align Technology (ALGN) United States $17.542B 44.76
Cardinal Health (CAH) United States $16.902B 11.35
Laboratory Of America Holdings (LH) United States $16.592B 15.02
Henry Schein (HSIC) United States $12.945B 21.28
Cooper (COO) United States $12.531B 22.57
DENTSPLY SIRONA (XRAY) United States $8.170B 16.32
Merit Medical Systems (MMSI) United States $3.175B 37.60
Patterson (PDCO) United States $2.334B 16.41
CONMED (CNMD) United States $1.914B 31.79
STAAR Surgical (STAA) United States $1.889B 194.59
Atrion (ATRI) United States $1.348B 38.53
Antares Pharma (ATRS) United States $0.523B 0.00
Invacare (IVC) United States $0.220B 0.00
Lifevantage (LFVN) United States $0.173B 24.54
Endologix (ELGX) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.057B 25.60
Aceto (ACET) United States $0.053B 0.00
Biolase (BIOL) United States $0.029B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00